Frost & Sullivan is honored to be named a '2025 Cross-Border Integration TOP Value Brand'

As a global leader in the consulting industry, Frost & Sullivan has always focused on technological innovation as its core driving force, dedicated to leading the digital transformation of the traditional consulting industry. By introducing advanced technologies such as AI, large models, and cloud computing, and innovatively proposing the 'Artificial Intelligence Empowered, Blockchain Technology Supported Knowledge Services (ABCK)' solution, Frost & Sullivan has taken the lead in deeply integrating knowledge services with digital tools in the industry. This has solved the pain points of 'information silos' and 'repeating the same wheel' in the traditional consulting industry, significantly improving service efficiency and accuracy. It is worth mentioning that as a professional research institution, Frost & Sullivan is also actively committed to providing high-quality research and consulting services for brands and society in the AI era. Frost & Sullivan cultivates industry-academia talents through open-source research and collaboration with universities, providing high-quality data support for large model training. At the same time, Frost & Sullivan is also actively involved in the formulation and promotion of industry standards, promoting the healthy development of AI technology. It hopes that through its own efforts, it can help brands build a clean online environment and a knowledge Great Wall in the AI era, enhancing the value and influence of brands.

Frost & Sullivan has been deeply involved in industry research for over 60 years, accumulating more than 10,000 original industry research reports and white papers in China. It spans across 19 core national economic industries and more than 6,000 sub-markets, providing in-depth analysis and trend predictions for various industries. In addition, Frost & Sullivan has published textbook-level publications such as 'White Paper on the Development Trends of China's Industries over the Next 50 Years', 'Investment Activity Report on the Issuance of 18A Biotech Companies in Hong Kong Stock Market', 'White Paper on the Development of Artificial Intelligence Industry in Hong Kong Stock Market', 'Hong Kong IPO and Secondary Market White Paper', and 'ESOP Equity Incentive Professional Plan' for many consecutive years in China. It has also cooperated with authoritative organizations including the China Academy of Information and Communications Technology, the Boao Forum for Asia Global Health Forum, and the Shanghai Stock Exchange to publish several industry white papers. In the field of life sciences, Frost & Sullivan maintains high-frequency and regular in-depth research outputs, releasing a large number of heavyweight industry white papers and blue papers every year, which have gained wide recognition from the capital market, industry, and investment community. From 2022 to 2024, it published three consecutive years with the 'Investment Activity Report on the Issuance of 18A Biotech Companies in Hong Kong Stock Market' (which includes not only 18A biotech companies in Hong Kong but also analyzes domestic science and technology innovation board biotech companies and those planning to go public), earning widespread praise from the industry for its influence and dissemination power.

Frost & Sullivan has also been actively advocating for industry integration, building cross-field dialogue bridges, and stimulating cross-border wisdom through its high-end exchange platforms such as the Frost & Sullivan Summit, which has been held in China for nearly 20 consecutive years and has been running continuously for nearly 30 years globally. Since 2022, Frost & Sullivan has hosted the New Investment Summit Forum in Life Sciences in China. Over the years, it has gathered more than 100 industry leaders, senior executives from biopharmaceutical companies, medical device companies, investment institutions, and professional service organizations, attracting over 1,000 professional attendees to jointly discuss new investment cooperation models, build a closer, more efficient, and win-win cooperation network, and jointly promote the vigorous development of the domestic and international life science industries. To this day, the Frost & Sullivan Summit has become an important platform for outstanding domestic enterprises, the investment community, and regulatory authorities to exchange successful experiences and jointly discuss development directions, as well as an important window for the world to understand China's most cutting-edge development trends.

Frost & Sullivan places great emphasis on and actively participates in the construction of 'Brand Powerhouses'. It has carried out in-depth strategic cooperation with highly influential institutions at home and abroad such as Xinhua News Agency's 'China Famous Brands', CCTV-1's 'Big Country Brands', and Forbes China Group, to jointly explore the value of Chinese enterprises and assist in the growth of Chinese brands. By integrating global resources with local insights, Frost & Sullivan has established a market position validation system and innovatively proposed the 'FSBVFrost & Sullivan Brand Value Model'. It has provided market position validation and brand valuation services to over 1,000 enterprises, continuously helping a large number of Chinese brands achieve growth strategies both domestically and overseas.

Dr. Wang Xin, Global Partner and Chairman of Frost & Sullivan Greater China, stated that we highly agree with the concept of 'cross-border integration, connectivity, and incremental value' proposed by Xinhua News Agency “China Famous Brands&rdquo., and will continue to promote the deep integration of the health industry with resources from multiple fields through innovative practices and professional services. This award for '2025 Cross-Border Integration TOP Value Brand' signifies that Frost & Sullivan's outstanding achievements in the field of cross-border integration have been highly recognized by the industry and market. In the future, Frost & Sullivan will continue to use technology as the engine, connectivity as the bond, and brands as the cornerstone to continuously empower the high-quality development of the health industry and contribute professional strength to building a new ecosystem of cross-border integration!